Patients with polymyalgia rheumatica have been shown to have an increased risk of peripheral arterial disease on longitudinal follow-up. Possible explanations for this include premature atherosclerosis related to chronic inflammation, as with other inflammatory rheumatological conditions. Alternatively, polymyalgia rheumatica can be associated with vasculitis, even in the absence of clinical giant cell arteritis, and peripheral vascular disease may represent subclinical vasculitis. Further work is required to elucidate the reasons for this increased risk. Currently, it would remain reasonable to aggressively control modifiable atherosclerotic risk factors. © 2009 BioMed Central Ltd.
CITATION STYLE
Borg, F. A., & Dasgupta, B. (2009, May 20). Peripheral arterial disease in polymyalgia rheumatica. Arthritis Research and Therapy. https://doi.org/10.1186/ar2685
Mendeley helps you to discover research relevant for your work.